-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Aspire Biopharma Holdings, Inc. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from 2021 to 2024.
- Aspire Biopharma Holdings, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $2.26M.
- Aspire Biopharma Holdings, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$11.7M, a 95.9% increase from 2023.
- Aspire Biopharma Holdings, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$285M, a 196% decline from 2022.
- Aspire Biopharma Holdings, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $297M.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)